Oraxinol By XYMOGEN Overview & Drug Interactions
Check For Interactions With Oraxinol
Supplement: Oraxinol by XYMOGEN
Oraxinol Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Oraxinol(TM)
| Ingredient Group | Proprietary Blend (Herb/Botanical) |
|---|---|
| Category | blend |
Drugs that interact with Oraxinol by XYMOGEN
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Oraxinol. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 60 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Oraxinol(TM) |
500 mg
|
Proprietary Blend (Herb/Botanical) |
--
|
| Other Ingredients: |
HPMC
Stearic Acid
Magnesium Stearate
|
|---|
Label Statments:
| FDA Statement of Identity |
- Dietary Supplement
|
|---|---|
| Suggested/Recommended/Usage/Directions |
- Directions: Take one capsule twice daily, or as directed by your healthcare practitioner.
|
| Precautions |
- Keep out of reach of children.
- • Pharmaceutical Grade • Professional Use Only
- CAUTION: Consult with your healthcare practitioner before use.
|
| FDA Disclaimer Statement |
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
| Storage |
- STORAGE: Keep tightly closed in a cool, dry place.
|
| Formula |
- Proprietary ORAC Blend Providing 6000 TE/g
|
| General Statements |
- EXCLUSIVE PROFESSIONAL FORMULAS
- This package is completely recyclable (recycle).
|
| General |
- TC# D4660601 REV. 022311
|
| Brand IP Statement(s) |
- XYMOGEN 2011
- (RosemarinX(TM)/Berr-X(TM))
- All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.
- Oraxinol(TM) is an innovative blend of standardized RosemarinX(TM) and Berr-X(TM) ORAC botanicals. ORAC [Oxygen Radical Absorbance Capacity] was developed by the National Institute of Aging and standardized by the U.S.D.A... ORAC is a measurement of antioxidants found in fruits and vegetables. The U.S.D.A... has found 5-9 servings of fruits and vegetables provide an average level of 6000 T.E. [trolox equivalents] required to minimize the effects free radicals may have on the aging process. Oraxinol(TM) helps bridge the gap between the recommended and actual daily consumption of fruits and vegetables.*
|
| Formulation |
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, sweeteners or preservatives.
|
| Seals/Symbols |
- VEGETABLE CAPSULES
|
Brand Information
See all products by this brand
| Researched, Developed & Distributed by: | |
|---|---|
| Name | XYMOGEN Exclusive Professional Formulas |
| Street Address | 725 S. Kirkman Rd. |
| City | Orlando |
| State | FL |
| ZipCode | 32811 |
| Phone Number | 800-647-6100 |
| Web Address | www.xymogen.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.